Polymer reptation is a process by which flexible linear polymers can migrate around obstacles and through pores and around other polymer molecules. It has successfully described quantitative behavior of polymer melts and has been invoked in explaining DNA separation according to length in sequencing gels. This mechanism may therefore be useful in delivering contrast agents or therapeutic drugs to tumors as these must traverse from the intravascular space through the tumor endothelial junction gaps and into the tumor. In this work, we show that polymers capable of weak interactions with tumor endothelium can translocate into the tumor interstitium at up to 9 times the rate of polymers without such cellsurface interactions. We propose a new mechanism by which the polymers diffuse along the cell surface and through cell junction gaps that occur in the tumor endothelium. This process can be halted in a number of ways that demonstrate that the surface interaction is essential for the higher transport rate. Alternative transport mechanisms are ruled out by further tests of polymer length scaling dependence, and by comparison of transport rates to those for globular constructs. Polymers of Gd-DTPA-polylysine and related backbones were investigated in an animal model of breast cancer and prostate cancer. Polymer lengths ranged from 30 nm to 300nm, (from 100 to 700 lysine residues) and the polymer constructs had a cross section of approximately 1.2 nm in radius. Polymer uptake rate into tumors for an equivalent hydrodynamic size globular macromolecule was some 135 times larger demonstrating the importance of this transport mechanism compared to free diffusion of globular macromolecules through the endothelium junction pores. The polymer length scaling, with monomer number N, on rate of tumor transport goes as N -1 , which rejects alternative transport processes such as pinocytosis, active transport, and particle like center of mass diffusion through pores. This N -1 scaling implies a cell-surface assisted polymer reptation process. This new transport mechanism allows very strong discrimination of aggressive tumors from nonaggressive tumors in animal model studies.
Introduction
Getting drugs and contrast agents into tumors is a challenge when the molecular size becomes large (1, 2) . Yet such large molecular weight constructs may carry useful payloads of therapeutic drugs or high payloads of imaging moieties that would be useful for early cancer detection and for effective therapy. Furthermore, small molecular weight imaging agents, when used in MR mammography, lead to significant false positives ( molecular weight agents, the so called blood pool agents, of higher molecular weight and not prone to loss in normal endothelium, have been found to be much more specific in preclinical studies (4) (5) (6) . The challenge resides mainly in the fact that although the tumor endothelium is known to be leaky, the size distribution of effective endothelial pores, in fact, drops off rapidly with pore size in animal model studies (7) . The number of pores of a given size drops of as r -4.5 in a range of test particles from 2 to 7 nm in radius. We have previously proposed that a linear extended polymer of small molecular cross section would be able to sample a larger distribution of small pores, and through polymer reptation be able to migrate through these pores into the tumor at a higher rate than globular molecules of the same hydrodynamic size as the polymer but restricted through geometric constraints to pores larger than its hydrodynamic size (8, 9) . However, there was no solution to the underlying problem for this mechanism of transendothelial transport, i.e., how does the polymer effectively orient to the pore opening or to the junction gap? Without such orientation we expect a rather slow process since polymer reptation along a convoluted 3-D path is a tortuous process with the center of mass moving slowly and giving a rapid decrease in the diffusion rate with polymer length (10, 11) . Thus, the rate of transport of longer polymers would rapidly decrease, resulting in a more limited range of effective polymer lengths for contrast or therapeutic agent delivery. To state the problem in another way, will the increase in the number of pores that can be interrogated by the polymer be balanced by the slower rate of transport of the long polymer through the pores?
How can a linear polymer achieve correct orientation to a pore opening or a narrow junction gap? This has not been clear. It was assumed that the increase in the number of possible pores that the linear polymer could traverse would be sufficient to explain the larger observed transport rate over equivalent hydrodynamic size globular molecules (8) . In this work, we explicitly identify a mechanism whereby the desired orientation with respect to a cell junction gap or pore is achieved. We propose that through weak cell surface interaction of the polymer such orientation can be achieved. And, by virtue of diffusion along a surface, such molecules can translocate into the tumor interstitium at an enhanced rate. When the surface interaction is removed -by elimination of the charge groups involved (i.e., dipolar charge configurations in a helical secondary structure of the polymer) or by infusion of cRGD dipolar molecules that interact with the purported integrin moieties on the cell surface -the enhanced rate of agent uptake disappears and a much slower rate of transport is observed in all cases. We will show that this reduction is in part due to lack of orienting forces on the polymer when the surface interactions are eliminated.
What of the polymer reptation process? In polymer melts, linear, unbranched polymers are not trapped in an entangled net, but through reptation (movement in a convoluted cylinder around other molecules in the polymer melt) are able to migrate (10, 11) . The effective center of mass movement in such a tortuous process is slow and the diffusion rate scales as N -2 , where N is the number of monomer units (11) . We test this prediction of scaling behavior and find that the rate of transport, i.e., the tumor permeability, decreases only as N -1 . This result supports the idea that the fundamental process in the translocation is a 2-dimensional diffusion process. Furthermore, the surface association automatically ensures the proper orientation of the long polymer axis to be in the plane of the junction gap through which the molecule must migrate. Hence, the problems associated with the initial hypothesis of polymer reptation transport across the endothelium are resolved. Additional experiments which explicitly alter the surface interactions through modification of the polymer charge distribution show that the transport rate is then markedly reduced. Other transport processes are considered but are not compatible with the observed length scaling behavior of N -1 .
The hypothesized cell surface interaction was based in part on molecular modeling of the linear charged polymer (9) and the observation that the charge dipoles on the polymer chain that are in the polymer constructs (chains of Gd-DTPA-polylysine with a few free positive lysine groups dispersed in the chain of negative Gd-DTPA residues) matches the dipole charge spacing of RGD moieties. Such peptide moieties are common on cell integrin molecules and provide a testable prediction for the proposed mechanism of transport: if RGD peptides are preinjected, the surface interaction of the polymer agents should be greatly attenuated and significant changes in transport rate should result.
Material and Methods

Polymer Agents
Gd-DTPA-polylysine was synthesized by previously described methods (12). The degree of conjugation with DTPA was 96% for 400 mer polylysine chains, the principal construct used in these studies, and between 92 and 97% for other constructs of shorter and longer length that were used to test the scaling behavior of transendothelial transport. The 4% of the remaining lysine groups provided the positive charge centers in the chain of negatively charged Gd-DTPA moieties.
In some experiments the remaining positively charged lysines groups on the Gd-DTPA-polymer were capped with trinitrobenzyle sulfate, TNBS (13) or with flourescein isothyonite. There were in those cases no positive charges left after the capping reactions. Similar capping reactions were reported previously with optical dye molecules, specifically with Cy5 (12). These constructs were further verified to have the same molecular conformation as the uncapped molecules by size exclusion chromatography (9, 12) .
To test further the effects of charge distribution on polymer agents, a Gd-DOTA-dextran agent, (a gift from P. Robert and C. Corot, Guerbet Laboratories) was also investigated and compared to polylysine polymers. The dextran polymer is designated as CMD-A2-Gd-DOTA, N=121, 30 negative charges grafted on, and no positive charges (14).
Globular Protein Agents
Gd-DTPA-albumin and Gd-DTPA-IgG were synthesized in a similar protocol to that above for polylysine and is described in detail in ref. (8) . Briefly, the mixed anhydride method was used in which the DTPA anhydride slurry was added to the protein solution (100 mg in 12 ml of 100 mM sodium bicarbonate). The coupling reaction proceeded for 16 hours and the purification and Gd labeling protocol was as for the polylysine constructs. Gd content was determined by ICP-APS.
Tumor Endothelial Permeability Measurements
In an animal tumor model, the rate of transendothelial transport, or polymer permeability was measured by MRI with a dynamic contrast enhancement method, DCE. Here the agent is injected and the tumor lights up immediately due to the increased blood volume of the tumor driven by tumor angiogenesis. This immediate MRI signal, i.e., the fractional signal change within 1 minute post injection, gives, therefore, a measure of the tumor fractional vascular volume or the tumor blood volume (here the immediate measurement is slow enough that factors associated with arterial input that are crucial in very fast DCE measurements with clinical agents are averaged out and effectively constant). Subsequently, as the agent enters extravascular space of the tumor, the MRI signal increases over the initial blood circulation signal, and this increase for long polymers is usually reasonably linear. The slope of the increasing signal gives a direct measure of the polymer permeability (or technically, the permeability-surface area product). The DCE measurement process is depicted schematically in Figure 1 and an experimental data set is shown in Figure 2 .
The quantitative expression for the observed signals in a two compartment model (15, 16) is derived from the expression for variation of agent concentration in the tumor:
where C 0 and C T are the intravascular and the tumor extravascular concentration respectively, and k 1 is the input transport rate into the tumor, in inverse time units, min -1 and k 2 is the rate of leaving the tumor, and γ is the clearance rate from the blood also in min -1 . The initial slope gives a good approximation of the input rate constant k 1 since the second term is small for low tumor concentrations. This is a matter of the kinetic rates in an actual experiment. Alternatively, Eqn.
[1] can be solved numerically to fit the observed data and k 1 can be derived explicitly even if the nonlinearity of the second term is substantially visible in the kinetic data.
The parameter of interest, permeability, or more precisely the permeability-surface area product, PS, is just the k 1 rate constant put into appropriate units (μmoles/min*gm). Thus, the usual parameter in dynamic contrast enhancement experiments, the PS term, the permeability-surface area product, is just PS = k 1 × 1000 μmoles/min*gm when C 0 is in μmoles/ml and k 1 is deduced from the rate of change of MRI signal in Eqn.
[2] below.
MRI Imaging
A GE Signa 1.5T scanner was used for the animal imaging. The receive coil was a cylindrical solenoid coil, 5 cm diameter, into which the animals were placed under anesthesia (an intraperitoneal injection of a mixture of acepromazine, xylazine, ketamine, and atropine). A T 1 spin echo sequence was used to generate the images: TE/TR 10/250, Nex 2, 12x12 Slope ‡ permeability permeability ‡ VV Time-- ‡ Figure 1 : Schematic for an ideal dynamic contrast enhancement, DCE, measurement of two hemodynamic parameters, vascular volume fraction VV and endothelial permeability using a slowly clearing macromolecular contrast agent. Vertical axis for red is the tumor signal change relative to preinjection, and top blue line is the circulating blood signal change, in an appropriate vessel, or the vena cava for example. These signal changes are directly related to concentration given the assumptions of Eqn. [2] . If the blood clearance rate is slow, as shown in this idealization, then the uptake into tumor is linear (before significant backflow from the tumor can take place, Eqn. [1]) and a measure of tumor permeability for the injected agent is derived from this slope. The initial signal shortly after agent injection is proportional to the fractional vascular volume of the tumor [see for example Ref. (17)]. Since the agent is slowly eliminated, the complications associated with arterial blood flow input and interstitial volume parameters are avoided in these types of DCE signal. FOV, 1mm slice thickness. An image was obtained prior to agent injection. At t=0 the contrast polymeric agent was injected by tail vein at dose of 0.025 μmole Gd/kg. The first image was obtained at t=1 minute and subsequent images were obtained every 4 minutes for up to 60 minutes post injection. In experiments with globular agents having a higher proton relaxivity the injection dose was corrected by the ratio of relaxivity values for polymer and globular agent, respectively.
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To quantify tumor permeability, regions of interest, ROI regions encompassing the whole tumor were taken for 3 to 4 image slices of the tumor. A signal enhancement curve was obtained for each image slice as a function of time using a histogram method for the signal change values for each pixel. Since the tumor permeability responses were heterogeneous as is well known in the literature, we used the highest 10 % of the responding pixels to define the angiogenically active tumor permeability areas (17). Inclusion of all the pixels in a tumor slice results in a dilution of the average signal changes in such a slice by a large number of unresponding pixels, associated with presumably necrotic regions of the tumor. In previous reports, in order to avoid signal dilution and focus on the active tumor regions, the analysis regions were operator defined and usually encompassed the tumor rim (8, 18). Unless otherwise specified the data below for tumor permeability are for the highest 10% of responding tumor pixels. Figure  2 shows a typical data set of dynamic contrast enhancement using Gd-DTPA-polylysine, N=400, for deducing tumor permeability in which both the high 10% of pixels are shown as well as the reduced average changes of all the pixels.
The relationship between permeability and the observed signal enhancement curve is given by Eqn.
[1] and the following expression for an imaging pixel signal change:
The left hand side represents the observed fractional changes in signal intensity for an imaging pixel at time t as defined with S(t) the signal at time t, and S 1 the signal immediately after injection, i.e., the blood volume signal, and S 0 is the signal before contrast agent injection. C T (t) is the concentration of agent in the tumor at time t, the extravascular component, R 1 is the proton longitudinal relaxivity of the agent (6), and T 1 is the proton relaxation time of the tissue prior to agent injection (usually about 1 sec at a field of 1.5T). The raw experimental data below are expressed as a dimensionless number, per cent enhancement per unit time, the left hand side of Eqn.
[2], per unit time, i.e., the observed slope of the fractional signal change of Eqn.
[2] in the dynamic enhancement data set. Data were taken at the same Gd injection dose (corrected when necessary for relaxivity differences from the standard polymer agent) and the raw DEC data can be compared directly without further transformation. The uptake slope in %/hr as shown in Figure 2 gives the k 1 value for the imaging pixel being examined according to Eqn. [1] , and, by the use of appropriate units for time and for the starting blood concentration, C 0 , the value can be converted to permeability-surface area product as indicated above.
Animal Models
A rat mammary adenocarcinoma cell line, Mat B3-13762, ATCC-CRL 1666, was used to implant into female Fisher 344 rats. Subcutaneous tumors were grown by implanting 2 × 10 6 cells in 0.2 ml Hank's balanced salt solution beneath the dorsal skin flap while the animal was anesthesized. After about 8-10 days the tumors reached a size of between 5 and 10 mm in diameter and the imaging experiments then commenced. Tumors larger than about 15 mm in diameter were not used in these studies as the presence of extensive necrotic regions negated the goal of assessing the active angiogenic tumor permeability and tumor blood volume in the viable regions of the tumor. Identical procedures were used for the other cell lines studied. The rat prostate cell lines Mat lylu B-2, ATTC CRL 2376, and AT1, ATTC JHU-29 were implanted in Copenhagen rats. The human breast cancer cell line MCF7 was implanted in immunodeficient SCID mice after first implanting estrogen pellets seven days prior to the tumor cells (The tumor cells were a gift from Z. Bhujwalla, Johns Hopkins) . Tumors grew to about 10 mm diameter in 3 to 4 weeks. Some tumors grew very much slower, requiring 8-12 weeks, and these were not included in the present study. The vascular volume fraction of these slow growing MCF7 tumors was about the same as for the fast growing tumors but the permeability to polymer agent was much smaller.
The vascular volume fraction deduced in our experiments with the MCF7 line could be directly compared to the litera- (17) for the highest 10% of responding pixels using equivalent agents (Gd-DTPAalbumin)]. The permeability values for the highest 10% of responding pixels for the two laboratories were, 1.5 +/-0.3 μl/ min*gm vs. 0.9 +/-0.4 μl/min*gm for this work and not statistically different. This verified that our DCE methods were in quantitative agreement with methods reported in the literature for the same tumor line and the same animal model.
All animal experiments were conducted in accordance with the approval of Institutional Animal Care and Use Committee and followed the New York State Health Department regulations.
Blocking Peptides
The peptide cRGD and a scrambled version of cRGD were obtained from GE Healthcare, Oslo, Norway. The peptides were injected into anesthesized animals by tail vein catheter followed by the injection of contrast agent 15 minutes later and the commencement of the DCE MRI measurements.
ECIS Determination of Cell Aggressiveness
Disruption of a confluent human umbilical vein endothelial cell, HUVEC, layer on gold electrodes (ECIS instrument, Applied Biophysics, Troy, NY) was used to test tumor cell aggressiveness by electrical cell-substrate impedance sensing, ECIS (19) . After establishment of a confluent cell layer of HUVEC cells, a high electrical impedance to ion flow from the gold electrode to a counter electrode in the tissue culture solution resulted, whereupon tumor cells were seeded at the same concentration in all cases. Electrical impedence was continually recorded with the instrument for up to 6 hours post injection. Disruption of the confluent endothelial cell layer results in a large decrease in the measured electrical impedance. This is the early step in the process of tumor cell invasion which has otherwise been monitored over several days by optical means in a Matri-gel assay (17). The rate of electrical impedance decrease gives a quantitative index of cell aggressiveness of the tumor lines used in these studies. The aggressiveness grading of Mat lylu and MCF7 cell lines by this method agrees with the qualitative measurements of cell invasion utilizing the Matri-gel assay and the measurements of incidence rate of metastasis in mice (17). Mat B cells are known to be metastatic but quantitative data are not available. AT1 cells are known to be non-metastatic (ATCC description of the cell line).
Hydrodynamic Sizes
Dynamic light scattering was used to determine hydrodynamic sizes of the globular and the polymeric agents as reported previously (7, 9) .
Polymer Conformation
Various polymers used in these experiments were analyzed for polymer conformation by size exclusion chromatography as previously described (9, 12) . All constructs in the present experiments eluted at the times predicted for an extended-linear conformation. A coiled polymer in a collapsed globular conformation elutes at a much later time for the same monomer number (9, 12). The lysine capping reactions did not change the linear extended conformation of the polymer agents as they eluted at the expected time for an extended-uncoiled confirmation.
Proton Relaxivity
The longitudinal proton relaxivity of the various molecular constructs was measured at a field of 1.5T and 25 ºC by standard methods (8). The R 1 relaxivity of the standard active polymer, Gd-DTPA-polylysine (N=400, 4% free lysines) was 8.5 +/-0.5 mM -1 sec -1 . The relaxivity of the other polymer constructs used in these experiments were in this range whereas the two globular agents, Gd-DTPA-albumin, and IgG-DTPAalbumin were both found to be much higher (as expected from literature results for albumin agents) , 15 +/-0.6 mM -1 sec -1 .
Results and Discussion
Polymer Length Scaling
How the rate of tumor uptake, i.e., permeability-surface are product, scales with polymer length is an important measurement which may lead to confirmation or rejection of various tumor uptake mechanisms. For example, in pinocytosis and vesicular transport there should be no dependence on the polymer length. Likewise, if the transport is dominated by a number of large pores there should also be little dependence on polymer length. If, however, the transport is a center of mass particle migration by 3-D diffusion hydrodynamics through an endothelial pore distribution, then as has been described previously (5), the scaling is very steep with hydrodynamic size -r -4.5 . On the other hand, polymer reptation in 3-D scales as N -2 , due to the tortuous cylindrical paths that the polymer may undertake to escape static entanglement (11).
In Figure 3 are shown the results for the rat mammary adenocarcinoma tumor model, the Mat B tumors. The power law fits indicates that the permeability scales as N -0.99 for the highest 10% of pixels, as N -0.86 for the highest 25% of pixels, and as N -0.75 for all pixels. This clearly disagrees with the prediction of 3-D polymer reptation scaling of N -2 . These results were checked on two other tumor models, Mat lylu and AT1, with observed scaling of N -0.86 and N -0.98 , respectively. Importantly, transport mechanisms such as specific uptake and endocytosis, pinocytosis, hydrodynamic center of mass diffusion through pores, 3-D polymer reptation, and transport by large pore dominance -all are inadequate to explain the observations for linear-extended polymer agents containing electric dipole centers along their negatively charged chains (Gd-DTPA-polylysine constructs of varying N, with ~ 4% free lysines along the chain). Pinocytosis and specific endocytosis would have a scaling exponent of 0: no dependence on length. Particle center of mass diffusion has a scaling behavior with respect to hydrodynamic radius with an exponent of -4.5 (7), which for 3-D diffusion for the linear polymers used translates to an exponent of -3.9 with respect to N by the use data on hydrodynamic radius vs. N obtained separately. Finally, as we have discussed above, 3-D reptation scales with a scaling exponent of -2 (11). Clearly, to explain the observed scaling a new, more specific transport model is required.
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On the Difference Between Polymer and Globular Agent Uptake
The need for a new transport mechanism is explicitly shown when tumor uptake rates of globular agents are compared to those for a linear polymer agent of an "active" configuration, i.e., polymers of a charge distribution and structure that allows for enhanced transport rates by as yet unspecified mechanism. In Figure 4 are shown uptake rates for two globular constructs, Gd-DTPA-albumin, Gd-DTPA-IgG, and compared to the polymer Gd-DTPA-polylysine (400 mer, 96% conjugation). The IgG agent uptake is very slow and importantly, no significant difference is observed between AT1 and MatB tumor lines, the non-aggressive, non metastatic tumor line and the aggressive, metastatic line.
The albumin agent, being smaller, does show a difference in uptake between these two cell lines but the differences is weak statistically as can be seen from the observed standard deviation error bars. The polymer uptake is higher and is very much higher for the aggressive Mat B tumor line than for the nonaggressive, AT1 tumor line. Evidently, a different transport process is involved in polymer transport than in the particle transport. The polymer transport process is able to discriminate these two tumor lines easily, whereas the globular transport process is able to weakly discriminate the tumors only for the smaller globular agent.
To further demonstrate that the two processes are very different, I plot data for just one tumor line, the Mat B tumors for the two types of agents, globular and extended-linear as a function of hydrodynamic radius in Figure 5 . The difference in transport behavior for particles and linear polymers as the hydrodynamic radius increases is dramatic. By varying the polymer conformation, through degree of DTPA substitution (9), linear polymers can be made to collapse to a smaller hydrodynamic size as shown by the arrow. This modest change in hydrodynamic size results in a profound change in tumor uptake rate. The hydrodynamic size collapses to 5.5 nm radius from 7.5 nm, and the permeability drops by more than an order of magnitude.
Polymer conformation and charge distribution are the driving factors in enhancing tumor uptake relative to particle uptake. Other experiments involving charged and uncharged Gd-DOTA substitutions on polylysine chains confirmed the importance of the negative charges in maintaining an unfolded linear conformation (20). However, the role of the few remaining positive charges and the resulting dipole centers on all of these polymer constructs was not appreciated until recently (12) . In that study, a variable number of remain- Figure 4: Tumor entry rate in terms of DCE signal slope, which is proportional to the permeability parameter of the tumor endothelium, for different size globular macromolecules and for the active polymer construct (Gd-DTPA-polylysine with 4% free lysine groups remaining after DTPA conjugation). Gd-DTPA-albumin is 3.5 nm in hydrodynamic radius, Gd-DTPA-IgG is 6.5 nm in hydrodynamic radius, and the reptating polymer agent is 1.2 nm cross section and 140 nm in length with 400 monomer units and has a hydrodynamic radius of 7.5 nm.
ing free lysines were capped with Cy5 dye. The uptake was modestly affected and steady from 1 to 11 Cy5 dye linkages from a total of 16 free lysines per polymer, but dropped precipitously when all the free lysines were capped as will be discussed below. Models of the molecular structure of Gd-DTPA-polylysine have been described previously (9) and in Figure 6 is shown a molecular model of the polymer at the apparently critical juncture of an electrically positive lysine group in a chain of helical negative groups, the Gd-DTPA moieties, which will be discussed in detail below.
Tumor cell line aggressiveness and polymer uptake rates
Using an electrical cell-substrate impedance assay, ECIS, we established the relative aggressiveness of each tumor line under study. It was found that the AT1 cells did not disrupt a confluent layer of endothelial cells (HUVAC) and Mat B and Mat lylu rapidly disrupted the endothelial layer, and the MCF7 line was intermediate in its disruption rate. In this way we established a quantitative aggressiveness index based on this assay In Figure 7 is shown the polymer uptake rate for each cell line vs. the aggressiveness index scale. The uptake rate by the polymer appears to increase linearly with aggres-siveness potential of the tumor line. This result is quite significant for its potential to distinguish tumor types and may arise due to the specific nature of the transport mechanism rather than just by a broad, general parameter such as tumor leakiness that is associated with particle transport. As shown in Figure 7 and in Figure 4 , the leakiness, or number of effective pores of a particular particle size increases somewhat when probed by an albumin agent of 3.5 nm hydrodynamic radius for aggressive vs. nonaggressive tumors [in agreement with literature results, for example Ref. (17)] but the disparity between aggressive and nonagressive tumor types is much greater when probed with the polymer agent. Therefore, the new mechanism associated with polymer uptake must provide the increased discrimination between the tumor types.
Effects of Charge Distribution
We have noted previously that a high degree of conjugation of Gd-DTPA to the polylysine backbone in excess of some 90% is necessary for good tumor uptake. This degree of conjugation ensures an extended unfolded conformation. In addition, the improved synthesis procedures eliminates the formation of intramolecular bonds via multiply activated Left fit is for the globular agent slope response with size and the right hand fit is for the linear polymer slope response with size.The hydrodynamic radius was determined by dynamic light scattering. The data of the left curve was presented in Ref. (7) and is given for comparison to the uptake characteristics of the polylysine agents (with some 2%-4% of monomers remaining as positively charged lysines, i.e., the cell-surface-active polymer agents). All experiments done for the same injection dose 0.025 μmole Gd/kg, corrected by the longitudinal proton R 1 relaxivity values for each agent relative to the standard polymer agent, 400 mer with 4% free lysines. The arrow points to a construction of a collapsed, folded N=400 polymer [with some 25% free lysines, see Ref. (9)] the hydrodynamic radius of which is reduced to 5.5 nm and whose DCE signal slope is hugely reduced as a result of this conformation change. DTPA entities in the coupling reaction of activated DTPA to the polylysine backbone. We were surprised to find that the tumor uptake is markedly reduced when all the remaining free lysines were capped with one of several dye molecules, such as Cy7 or Cy5 whereas if only a fraction of the free lysines were capped, up to 11/16 for example, the uptake remained strong (12). This drop in transport rate was mysterious and could have been a curious peculiarity associated with the dye molecule structure and the dye molecule interaction with the polymer chain, although all measurements as to conformation indicated that the inefficient capped polymers still maintained their proper extended conformation.
To extend this unexpected observation, we used several other capping reactions and investigated their effects on tumor uptake. The free lysines were thoroughly capped by TNBS. When this was done, the uptake efficiency dropped to a low value, by approximately a factor of 9 from the uncapped version. Yet another capping reaction was used in which fluoroscein isothyanate was linked to the remaining free lysines. Again, as shown in Table I , the uptake dropped by approximately a factor of 9.
Finally, we compared the active polymer uptake rate to a dextran based polymer, with just 30 negative charges on a chain of 121 residues containing also, 35 neutral Gd-DOTA moieties. When compared to an active polylysine polymer of equivalent length the uptake is again low as indicated in Table I. To summarize, having a few positive charges -it is not clear whether the minimum number is 1 or as high as 4 for a 400 mer polymer (12) -along the polymer chain is essential for efficient transendothelial transport. Elimination of the lysine charges by one of several capping reactions produces an inactive polymer agent, one whose uptake is some factor of 9 lower than in the uncapped version. Further, a different polymer based on a dextran backbone containing only a set of randomly distributed negative charges also exhibits reduced uptake efficiency as indicated in Table I . The observed dextran agent slope was 225 +/-50%/hr for N=121 and the capped polylsine agents at N=402 were approximately 30%/hr as indicated. This is consistent with N -2 scaling (225 → 25) and not to N -1 scaling. Therefore, to bring the dextran data into the table for the same polymer length as used with the polylysine constructs, I have used the N -2 scaling. This of course is quite different from what was found for polymers with cellsurface binding interactions present, Figure 3 , for which the scaling is as N -1 for all the three tumor lines tested.
Interactions with Cell Surface Integrins and Interference of cRGD
The above observations indicate that a set of randomly distributed lysines in a chain of negative charges seems necessary for tumor uptake efficacy. A possible clue is the structure of the polymer chain. We have shown that the modeling of the chain suggests a helical Gd-DTPA conformation around the peptide backbone that was confirmed by circular dichroism measurements (9). An isolated lysine in such a helix produces a slight bend in the chain and the surrounding negative charges produces a dipolar charge potential-well that would geometrically accept the tri-amino acid dipolar peptide RGD as depicted in Figure 6 . Thus, I hypothesize that the RGD like motifs on cell surface integrins may interact with the dipolar charge potential-wells existing on the polymer chain. And, that this interaction may be the key to the transport mechanism. The hypothesis suggests two effects that should be detectable: (i) preinjection of cRGD peptides should interfere with such interactions and reduce uptake, and (ii) the effects of polymer interaction with the tumor endothelium should be Figure 7 : Permeability-surface area product, PS for high 10% of responding pixels, vs. aggressiveness index derived from ECIS assay for the different cell lines observed. Error bars are for standard deviation. Permeability is relative to the value observed for albumin agent and the AT1 cell line, aggressiveness index of 0, as these tumor cells have no effect on confluent cell layers in ECIS measurements. 2.1+/-0.3 1 †Polymers: Gd-DTPA-polylysine, N=402, 4% free lysines, r H = 7.5 nm; Capped polymers have no free lysines. Globular molecule data taken from ref. (7), and extrapolated to r H = 7.5 nm to match the r H value of the polymer contrast agent, N=402. ‡Dextran agent (ref. 14): N=121, with random distribution of negative charges on 35 residues. Observed uptake slope corrected for length to N=402 by using N-2 scaling, see text.
detectable as an increase in the effective blood volume (i.e., freely circulating agent in addition to surface bound agent would contribute to a larger initial blood volume signal) if the surface binding is sufficient for signal detectability.
With regard to prediction 1, Figure 8 shows that, indeed, the cRGD preinjection reduces subsequent polymer uptake whereas a scrambled peptide having no fixed RGD dipolar motif fails to inhibit polymer uptake.
This result is also summarized in Table I above. Data on prediction 2 is shown in Figure 9 . There is a detectable change in apparent blood volume when the initial signal for the case of cRGD preinjection is compared to no preinjection and with preinjection of a scrambled peptide.
The change in signal, δ, when cRGD is preinjected, is an indication of a polymer interaction with the endothelium in which a fraction of the polymer are sequestered at the endothelium surface and the other polymer fraction is the freely circulating polymer. (Note that for these long polymers of N=400, the extravascular tumor component is negligible at 1 minute post injection, see Fig. 2 for example). By way of a control experiment, there is negligible change in the blood volume signal if a scrambled peptide is preinjected. On this basis, one would also expect that globular agents would give a smaller blood volume signal than the active polymer agents since there is not expected to be any interaction between Gd-DTPA-albumin and the endothelium. This was found to be the case, the initial signal for identical effective Gd dose, i.e., corrected for relaxivity differences, gives a blood volume signal of 40% +/-7% whereas as indicated in Fig.9 , the reptating polymer gives a blood volume signal of 58% +/-7%. Lower initial fractional signal changes were also observed for the capped polymers (31% +/-12%).
Such a surface interaction with polymer should also show scaling behavior: A linear dependence of the δ component with polymer length (i.e., more Gd per polymer binding event since the number of Gd ions carried by polymer for the same high conjugation is proportional to the monomer number). This was observed for polymer lengths ranging from N=100 to N= 780 (data not shown). Also it was observed that the δ signal component relative to the circulating component decreased inversely with dose: the surface associated component becomes fractionally smaller with high dose of agent since the circulating value is not limited and the surface association is limited to the number of binding sites on the endothelium.
What would be the density of such inferred binding sites? Using some reasonable assumptions on capillary size, and tumor blood volume, (10 μm capillaries at a fractional vol- The initial signal change for the high 10% of responding pixels relative to preinjection signal values, at 1 minute post injection, (S 1 -S 0 )/S 0 , of Gd-DTPA-polylysine (N=400, 4% free lysines). This initial fractional signal change corresponds to the apparent fractional blood volume of the highest 10% of responding pixels in the Mat B tumors and occurs before any extravascular transport can take place for this long polymer. The scrambled peptide and the cRGD peptide are injected 15 minutes before the polymer injection (n=3, 3, and 2, respectively, and the standard deviation of the initial signal was 7, 12, and 15, respectively). The decrease δ with respect to the polymer initial signal alone reflects a change in the apparent fractional blood volume as a result of the cRGD injection and does not occur for the case of scrambled peptide injection. ume of 5% and 5 × 10 μm endothelial cells), it is straightforward to calculate that a δ component of some 20% in the initial signal change, (S 1 -S 0 )/S 0 , corresponds to some 7.5 × 10 4 binding sites per endothelial cell (for 400 Gd ions per polymer at an R 1 of 8.5 mM -1 sec -1 and T 1 of 1 sec) using Eqn.
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[2]. This is a large number of sites per cell but not unreasonably so, particularly when we consider that rather nonspecific RGD type moieties of endothelial cell integrins are involved in the binding interactions.
Cell Surface Assisted Reptation Model
These results, taken together, point to a transport mechanism that is dependent on polymer-endothelial cell surface interactions. The data and the molecular modeling suggest an interaction between the dipolar lysine bends on the polymer chains and the dipolar charges on RGD moieties of cell surface integrins. This interaction is likely to be weak, allowing for diffusion along the cell surface to take place. In this way, the problem of polymer orientation with respect to cell gap junctions is solved: The long axis of the polymer is never in opposition to the plane of the junction as the polymer chain is constrained to the surface as it migrates toward the junction. This process is shown schematically in Figure 10 .
In the simplest case, the problem then becomes one of diffusion in 2-D and hence the scaling law approaches that which is expected from friction coefficient calculations for free diffusion, i.e., f ≈ r H where r H is the hydrodynamic radius in the Einstein relationship for molecular diffusion D=kT/f. Therefore, for such free 2-D diffusion, the scaling law would depend on N as N -0.6 since r H for these flexible polymers was determined to scale as r H ∝ N 0.6 from light scattering measurements on the polymer constructs (whereas rigid rods can be calculated to scale as r H ∝ N 0.79 ). The free 2-D diffusion scaling exponent of -0.6 is not consistent with the observed exponents of -0.99, -0.86, and -0.98 for the three tumor lines studied. The observed scaling behavior probably reflects a deeper process involving 2-D reptation of the polymer and not just simple 2-D diffusion: There are likely to be obstacles in the gap junction around which the polymers must migrate. Therefore, there is a bigger penalty extracted for being long than in the case of free diffusion alone: the penalty being a -1 exponent in the length scaling rather than -0.6. Unfortunately, there is at this time no mathematical expression for surface reptation scaling, although intuitively it seems reasonable to expect a scaling exponent drop from -2 to -1 as the dimensionality goes from 3-D to 2-D. This theoretical question remains to be explored.
To summarize, the observed scaling is substantially as 1/N, it is not consistent with free 2-D diffusion process but is in fact significantly steeper. Some migration around obstacles in the gap junctions may still be rate limiting. We therefore describe this transport process as cell-surface-assisted polymer reptation.
The question arises whether such a process exists in normal tissues as in muscle or in the kidney or liver. There is no evidence for extravascular uptake in muscle nor to any surface binding effects in muscle endothelia: muscle signals decrease after injection with approximately the same rate constant as found for large arteries or veins (the blood elimination rate) and the initial signals are invariant as to agent type or to the presence of blocking peptides. Observations of kidney and liver signals, which are much larger, do not show any endothelial surface interaction effects: the initial signals associated with circulating agent are not statistically different for a variety of different agents and with and without preinjection of blocking peptides. We conclude that the surface interactions between appropriately charged polymers and endothelial cells appear to be confined to tumor endothelium and is therefore associated with angiogenic processes and perhaps connected with tumor invasive processes as the data of Figures 4 and 7 suggest.
Polymer Reptation Without Cell Surface Interactions
As Table I indicates, polymer reptation in 3-D (for the nonsurface interacting polymer agents) can lead to translocation through tumor endothelia that would exclude globular constructs of equivalent hydrodynamic size. In such a comparison there is a significant enhancement over the equivalent globular construct, by a factor of 15 or so. This factor arises Figure 10: Cartoon of proposed transport process through the tumor endothelium cell junction. Polymer with positive lysine groups, red, in the chain of negative charges, green, at some reasonably low density on the chain (detailed depiction in Figure 6 ), interacts with cell surface integrins depicted as red cones, and migrates along the surface and through the junction gap. When the surface binding is eliminated by capping of the red charge centers or by cRGD peptide interference, then this process is inactive and the rate of tumor entry is much reduced for a given polymer, Table I . The length scaling law exponent for this process is found to be -1 and this suggests a 2-D reptation process along the cell surface which insures that the polymer long axis is more or less parallel to the cell surface. In the absence of this orienting interaction the polymer long axis may be oriented across the junction and a full 3-D polymer reptation process would be required to cross the junction, a much slower process, Table I. from the increase in the number of effective pores that a polymer of a small cross section can sample, but is very much reduced by the nature of 3-D reptation: the center of mass migration in a tortuous convoluted path is very slow and not subject to calculation from first principles; although the N -2 scaling can be derived from general principles alone (11) the actual friction coefficient value cannot. Interestingly, however, given the pore distribution that was observed (7), it is possible to estimate that the reptation process in 3-D produces a migration that is some 200 times slower than would be found for a particle of the same size as the cross section size of the polymer (and for polymer of N=400). For nonsurface interacting polymers we would predict a scaling law of N -2 . And so, in this case, short polymers would be very much more effective than long polymers. The tumor uptake rate of non-cell surface interacting longer polymers rapidly decreases with polymer length consistent with N -2 scaling, but only two data points were observed; that for N=121, the dextran constructs, and the N=400 capped polymer molecules.
Significance
What is the significance of cell surface-assisted polymer reptation? As Figure 7 illustrates, the distinction between aggressive and nonaggressive tumor lines is made quite distinct through this mechanism. The trans-endothelial transport of globular agents gives a much less distinct difference and for large globular agents there is no significant difference. Thus, the number of large endothelial pores is not different between aggressive and non-aggressive tumors. The distinction appears to lie in the numbers of smaller or intermediate size pores. Importantly, the studies with clinical agents of small molecular size have not yielded significant reliable differences between benign and malignant tumors in preclinical studies due to a number of confounding factors such as differences in extra-cellular volume and blood flow into the tumors (4-6). Also, polymer 3-D reptation alone may not be sufficient to distinguish tumor types reliably given the recent report on the use of the polymeric dextran agent above and the inability of this agent to distinguish aggressive from benign tumors (21).
Thus, there is a need for contrast agents that would enable accurate means of tumor staging and prognosis through imaging without recourse to painful and stressful biopsy procedures and there is a need for transporting larger molecular weight drugs into tumors (22). The transport mechanism described here may allow for such needs to be met by appropriate molecular design of contrast agents and carriers of therapeutic drugs.
The improved distinctions between tumor types may be simply due to a larger number of small pores that the polymers are able to access in the aggressive tumors. But this does not seem to be supported by the recent study with the dextran agent (21). Alternatively, the distinction between tumor types may arise from differences in the cell-surface assisted process itself and may point to a new tumor biology feature that could be exploited in more general ways. Changes in the cell-surface assisted polymer transport rates may reflect changes in the tumor endothelium associated with tumor invasive processes.
This new transport mechanism implies tumor endothelial process that may be exploited in other ways not only to identify aggressive tumors but also to perhaps point to new ways of delivering therapy to such tumors or to constructing improved contrast agents not only for MRI but for other modalities.
